J Clin Pharmacol
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     

Sign In to gain access to subscriptions and/or personal tools.
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (5)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lee, S. S. C.
Right arrow Articles by Chow, M. S. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lee, S. S. C.
Right arrow Articles by Chow, M. S. S.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

TEACHING SERIES

Benefits of Individualized Counseling by the Pharmacist on the Treatment Outcomes of Hyperlipidemia in Hong Kong

Suzanne Shuk Ching Lee, BPharm, Pui-Yin Pauline Cheung, PharmD and Moses Sing Sum Chow, PharmD

From Pharmacy Department, Tsuen Wan Adventist Hospital, Hong Kong (Ms. Lee); School of Pharmacy, Chinese University of Hong Kong (Dr. Cheung); and School of Pharmacy, Chinese University of Hong Kong (Dr. Chow).

A prospective controlled study on the benefits of pharmacists' individualized counseling on drug compliance, cholesterol concentration reduction, attainment of National Cholesterol Education Program (NCEP) Adult Treatment Panel III (ATP III) low-density lipoprotein cholesterol (LDL-C) goals, and patient satisfaction was carried out in a private community hospital in Hong Kong. All patients who were newly prescribed with lipid-lowering drugs for primary prevention were included. The patients in the individualized counseling group received "intense" counseling and follow-up of cholesterol concentration by a pharmacist for 3 months. The control group received routine counseling. Fifty patients completed the study (26 in the individualized group, 24 in the control group). Compliance was assessed, and those patients who achieved 75% compliance were defined as compliers. In the individualized group, 76.9% were compliers compared with 41.7% in the control group (p < 0.01). The individualized group achieved 28.3%, 27.7%, and 26.1% reduction in total cholesterol, LDL-C, and triglycerides, respectively, compared with 15.3%, 16.3%, and 10.6% in the control group (p < 0.05 for all). Also in the individualized group, 80.8% achieved the ATP III LDL-C goals compared to 58.3% in the control group (p < 0.05). Of patients in the individualized group, 85% felt that the pharmacist counseling service could improve their disease management. The study demonstrated that pharmacists' individualized counseling, together with the assessment of cholesterol concentrations, had positive impacts on the management of hyperlipidemia, including improved drug compliance, better treatment endpoints, and patient satisfaction.


Key Words: Individualized counselingpharmacistshyperlipidemiacardiovascular diseasedrug compliance

Address for reprints: Moses Sing Sum Chow, School of Pharmacy, 6/F, Choh Ming Li Basic Medical Sciences Building, Chinese University of Hong Kong, Shatin, N.T., Hong Kong.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
The Annals of PharmacotherapyHome page
M. Machado, N. Nassor, J. M Bajcar, G. C Guzzo, and T. R Einarson
Sensitivity of Patient Outcomes to Pharmacist Interventions. Part III: Systematic Review and Meta-Analysis in Hyperlipidemia Management
Ann. Pharmacother., September 1, 2008; 42(9): 1195 - 1207.
[Abstract] [Full Text] [PDF]


Home page
J Am Board Fam MedHome page
G. Rust and L. A. Cooper
How Can Practice-based Research Contribute to the Elimination of Health Disparities?
J Am Board Fam Med, March 1, 2007; 20(2): 105 - 114.
[Abstract] [Full Text] [PDF]


Home page
JAMAHome page
R. J. Simpson Jr
Challenges for Improving Medication Adherence
JAMA, December 6, 2006; 296(21): 2614 - 2616.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2004 by the American College of Clinical Pharmacology